Effects of the COVID-19 Restrictions on Eating Behaviour and Eating Disorder Symptomology in Female Adolescents.
Lois MuthKarl-Heinz LevenGunther MollOliver KratzStefanie HorndaschPublished in: International journal of environmental research and public health (2022)
Confinement due to the COVID-19 pandemic imposes a burden on adolescents worldwide and may seriously impact patients with an eating disorder (ED). The current FR anconian A norexia N ervosa during CO VID-19 (FRANCO) study explored (1) perceived change of depressive and ED symptomology during lockdown, (2) the role of social media, and (3) coping strategies of anorexia nervosa (AN) patients and clinical as well as healthy comparison groups. From June 2021 to September 2021, 222 female adolescents (19 with AN, 20 with depression, 45 with a self-reported psychiatric disorder (SRPD), and 138 controls) aged 11.2 to 18.9 years completed a one-time anonymous survey retrospectively reporting back on ED and depressive symptomology before and during the pandemic, the impact of social media, and coping strategies. A reduced quality of life (QoL) due to confinement was observed in almost half of female adolescents. All groups reported a significant perceived increase of disordered eating, overeating, anxiety, and depressive symptoms and emotion-regulation problems. In AN patients, significantly higher percentual deterioration of disordered eating and anxiety and depressive symptoms was found. For controls, a younger age and higher susceptibility of the sociocultural body image significantly correlated with increased disordered eating. Large-scale media literacy interventions are recommended.
Keyphrases
- depressive symptoms
- social media
- physical activity
- social support
- young adults
- end stage renal disease
- sleep quality
- emergency department
- health information
- coronavirus disease
- ejection fraction
- mental health
- newly diagnosed
- chronic kidney disease
- sars cov
- weight loss
- peritoneal dialysis
- prognostic factors
- anorexia nervosa
- stress induced
- cross sectional
- adverse drug
- clinical evaluation
- respiratory syndrome coronavirus